GlaxoSmithKline gifted Pfizer consumer health advantage by Reckitt

NEW YORK/LONDON (Reuters) – British consumer goods group Reckitt Benckiser has pulled out of talks to buy Pfizer’s consumer healthcare business, strengthening rival bidder GlaxoSmithKline’s hand.

Source: Reuters

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>